FRONT COVER |
1 |
OUR VISION, OUR MISSION & CORE VALUES |
2 |
TABLE OF CONTENTS |
3 |
WORLDWIDE OPERATION |
4 |
CORPORATE PROFILE |
5 |
CORPORATE INFORMATION |
6 |
FINANCIAL HIGHLIGHTS |
7 |
CORPORATE CALENDAR |
8 |
CORPORATE RESPONSIBILITY STATEMENT & CALENDAR |
10 |
HEALTH, SAFETY AND ENVIRONMENT |
11 |
MANAGEMENT DISCUSSION AND ANALYSIS |
13 |
BOARD OF DIRECTORS |
19 |
PROFILE OF THE BOARD OF DIRECTORS |
20 |
PROFILE OF THE KEY SENIOR MANAGEMENT |
22 |
AUDIT COMMITTEE |
25 |
REMUNERATION COMMITTEE |
29 |
NOMINATION COMMITTEE |
32 |
STATEMENT ON CORPORATE GOVERNANCE |
36 |
ADDITIONAL COMPLIANCE INFORMATION |
53 |
STATEMENT ON RISK MANAGEMENT AND INTERNAL CONTROL |
54 |
STATEMENT OF DIRECTORS’ RESPONSIBILITY |
56 |
FINANCIAL STATEMENTS |
57 |
DIRECTORS’ REPORT |
58 |
STATEMENT BY DIRECTORS |
63 |
STATUTORY DECLARATION |
63 |
INDEPENDENT AUDITORS’ REPORT |
64 |
STATEMENTS OF FINANCIAL POSITION |
71 |
STATEMENTS OF PROFIT OR LOSS |
73 |
STATEMENTS OF OTHER COMPREHENSIVE INCOME |
74 |
CONSOLIDATED STATEMENT OF CHANGES IN EQUITY |
75 |
COMPANY STATEMENT OF CHANGES IN EQUITY |
77 |
STATEMENTS OF CASH FLOWS |
78 |
NOTES TO THE FINANCIAL STATEMENTS |
82 |
GENERAL INFORMATION |
82 |
SIGNIFICANT ACCOUNTING POLICIES |
82 |
CRITICAL ACCOUNTING ESTIMATES AND JUDGEMENTS |
105 |
PROPERTY, PLANT AND EQUIPMENT |
107 |
PREPAID LEASE PAYMENTS |
112 |
BIOLOGICAL ASSETS |
114 |
INVESTMENT PROPERTIES |
114 |
INVESTMENT IN SUBSIDIARIES |
116 |
INVESTMENT IN ASSOCIATES |
127 |
INVESTMENT IN JOINT VENTURES |
132 |
FINANCE LEASE RECEIVABLES |
139 |
AVAILABLE-FOR-SALE FINANCIAL ASSETS |
139 |
DERIVATIVE FINANCIAL ASSETS/(LIABILITIES) |
140 |
GOODWILL AND OTHER INTANGIBLE ASSETS |
141 |
DEFERRED TAX ASSETS/(LIABILITIES) |
144 |
INVENTORIES |
146 |
AMOUNTS DUE FROM/(TO) CUSTOMERS ON CONTRACTS |
146 |
TRADE AND OTHER RECEIVABLES |
147 |
AMOUNTS OWING BY/(TO) SUBSIDIARIES |
150 |
AMOUNTS OWING BY/(TO) ASSOCIATES |
152 |
AMOUNTS OWING BY/(TO) JOINT VENTURES |
153 |
TIME DEPOSITS |
154 |
CASH AND BANK BALANCES |
155 |
ASSETS CLASSIFIED AS HELD FOR SALE |
155 |
SHARE CAPITAL |
156 |
SHARE PREMIUM |
157 |
TREASURY SHARES |
157 |
OTHER RESERVES |
158 |
LOANS AND BORROWINGS |
158 |
TRADE AND OTHER PAYABLES |
161 |
PROVISION FOR WARRANTIES |
162 |
GROSS REVENUE |
163 |
COST OF SALES |
163 |
OTHER GAINS - NET |
163 |
(LOSS)/PROFIT FROM OPERATIONS |
164 |
FINANCE COSTS |
166 |
TAX EXPENSE |
166 |
(LOSS)/EARNINGS PER SHARE ATTRIBUTABLE TO OWNERS OF THE COMPANY |
167 |
DIVIDENDS |
168 |
DISPOSAL OF SUBSIDIARIES |
168 |
SIGNIFICANT RELATED PARTY DISCLOSURES |
170 |
STAFF COSTS |
173 |
COMMITMENTS |
173 |
MATERIAL LITIGATION |
174 |
SEGMENTAL ANALYSIS |
176 |
FINANCIAL INSTRUMENTS BY CATEGORY |
182 |
FINANCIAL RISK MANAGEMENT OBJECTIVES AND POLICIES |
183 |
FAIR VALUES OF FINANCIAL INSTRUMENTS |
187 |
CAPITAL MANAGEMENT |
189 |
SUPPLEMENTARY INFORMATION DISCLOSED |
190 |
SUMMARY OF SIGNIFICANT RECURRENT RELATED PARTY TRANSACTIONS |
191 |
TOP 10 LIST OF PROPERTIES |
196 |
ANALYSIS OF SHAREHOLDINGS |
198 |
NOTICE OF SEVENTEENTH ANNUAL GENERAL MEETING |
201 |
STATEMENT ACCOMPANYING NOTICE OF SEVENTEENTH ANNUAL GENERAL MEETING |
207 |
PROXY FORM |
209 |
BACK COVER |
212 |